How Private DNA Data Led Idaho Cops on a Wild Goose Chase and Linked an Innocent Man to a 20-year-old Murder Case
By Jennifer Lynch,
Electronic Frontier Foundation
| 05. 01. 2015
Untitled Document
The New Orleans Advocate recently published a shocking story that details the very real threats to privacy and civil liberties posed by law enforcement access to private genetic databases and familial DNA searching.
In 1996, a young woman named Angie Dodge was murdered in her apartment in a small town in Idaho. Although the police collected DNA from semen left at the crime scene, they haven’t been able to match the DNA to existing profiles in any criminal database, and the murder has never been solved.
Fast forward to 2014. The Idaho police sent the semen sample to a private lab to extract a DNA profile that included YSTR and mtDNA—the two genetic markers used to determine patrilineal and matrilineal relationships (it’s unclear why they reopened the case after nearly 20 years). These markers would allow investigators to search some existing databases to try to find a match between the sample and genetic relatives.
The cops chose to use a lab linked to a private collection of genetic genealogical data called the Sorenson Database (now owned by Ancestry.com...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
